ALCEX | RMEBX | ALCEX / RMEBX | |
Total Expense Ratio | 0.00 | 1.07 | - |
Annual Report Gross Expense Ratio | 0.15 | 1.07 | 14% |
Fund Existence | 3 years | 11 years | - |
Gain YTD | -0.212 | 5.923 | -4% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 413M | 106B | 0% |
Annual Yield % from dividends | 1.80 | 1.16 | 155% |
Returns for 1 year | 7.61 | 8.54 | 89% |
Returns for 3 years | N/A | 27.89 | - |
Returns for 5 years | N/A | 58.69 | - |
Returns for 10 years | N/A | 68.22 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
LYFIX | 12.30 | -0.07 | -0.57% |
AlphaCentric Life Sciences & Hlthcare I | |||
TNBRX | 19.48 | -0.21 | -1.09% |
1290 SmartBeta Equity R | |||
VLMIX | 35.00 | -0.46 | -1.30% |
Value Line Mid Cap Focused Institutional | |||
BFTUX | 60.44 | -0.86 | -1.40% |
Baron Fifth Avenue Growth R6 | |||
PLGIX | 16.87 | -0.27 | -1.58% |
Principal LargeCap Growth I Instl |